<i>Materials and Methods</i>: This retrospective multicenter study included 332 patients with metastatic NSCLC harboring oncogenic alterations (EGFR, ALK, ROS1, KRAS, and others) from eight oncology centers in Türkiye. This evidence concerns the gene ALK and non-small cell lung carcinoma.